The aim was to evaluate the published literature to assess what is conclusively known about optimal technique and outcome for foam sclerotherapy.
Methods
A literature search was performed for randomised controlled trials, meta-analyses and observational studies using appropriate statistical techniques with survival analysis for long-term outcome.
Results
Foam is more effective than liquid for ultrasound-guided sclerotherapy. Both sclerosants commonly used are equally effective for sclerotherapy for small veins. Ultrasound signals appear in the systemic circulation in most patients after foam sclerotherapy but do not appear to be associated with serious complications.
Conclusion
Little else is known about the optimal preparation of foamed sclerosants and the best technique for administering foam for sclerotherapy. Long-term studies are required to determine outcome for various techniques. There is an opportunity for many controlled trials to assess results.
WinterbornRJ, CorbettCR. Treatment of varicose veins: the present and the future – a questionnaire survey. Ann Roy Coll Surg Engl2008;90:561–4
2.
TessariL, CavezziA, FrulliniA. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg2001;27:58–60
3.
BreuFX, GuggenbichlerS, WollmannJC. 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa2008;37(Suppl. 71):1–29
4.
RigbyKA, PalfrymanSSJ, BeverleyC, MichaelsJA. Surgery versus sclerotherapy for the treatment of varicose veins (Review). Cochrane Database Syst Rev2004;10:CD004980
RedondoP, CabreraJ. Microfoam sclerotherapy. Semin Cutan Med Surg2005;24:175–83
7.
CabreraJ. UK Patent Application No. 0422307.9, filed 7 October 2004
8.
ParsiK, ExnerT, ConnorDE, The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro. Eur J Vasc Endovasc Surg2008;36:216–23
9.
ParsiK, ExnerT, ConnorDE, In vitro effects of detergent sclerosants on coagulation, platelets and microparticles. Eur J Vasc Endovasc Surg2007;34:731–40
10.
OrsiniC, BrottoM. Immediate pathologic effects on the vein wall of foam sclerotherapy. Dermatol Surg2007;33:1250–4
11.
AlòsJ, CarreñoP, LópezJA, Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg2006;31:101–7
12.
RabeE, OttoJ, SchliephakeD, PannierF. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg2008;35:238–45
13.
OuvryP, AllaertFA, DesnosP, Hamel-DesnosC. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up. Eur J Vasc Endovasc Surg2008;36:366–70
14.
YamakiT, NozakiM, SakuraiH, Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg2008;47:578–84
15.
RaoJ, WildemoreJK, GoldmanMP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg2005;31:631–5
16.
RabeE, SchliephakeD, OttoJ. Polidocanal, sodium tetradecyl sulphate and placebo for sclerotherapy of C1-varicose veins: a double-blind, randomised, controlled clinical trial (EASI-study). Phlebology2009;24:86
17.
CeulenRP, Bullens-GoessensYI, Pi-Van De VenneSJ, Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol Surg2007;33:276–81
18.
Hamel-DesnosC, OuvryP, BenigniJP, Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. ‘The 3/1 Study’. Eur J Vasc Endovasc Surg2007;34:723–9
19.
MyersKA, JolleyD, CloughA, KirwanJ. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg2007;33:116–21
20.
TessariL, CavezziA, RossM, Cabrera GarridoA. Variables in foam sclerotherapy: literature and experimental data. Aust NZ J Phlebology2008;11:83–4
21.
ShiraziAR, GoldmanM. The use of a 5-microm filter hub increases foam stability when using the double-syringe technique. Dermatol Surg2008;34:91–2
22.
LaiSW, GoldmanMP. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?J Drugs Dermatol2008;7:399–400
23.
HillD. Comparison of foam stability by foam composition. Phlebology2009;24:86
24.
KernP, RameletAA, WütschertR, HayozD. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. J Vasc Surg2007;45:1212–6
PascarellaL, BerganJJ, MekenasLV. Severe chronic venous insufficiency treated by foamed sclerosant. Ann Vasc Surg2006;20:83–91
27.
van den BosR, ArendsL, KockaertM, Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg2009;49:230–9
28.
LuebkeT, BrunkwallJ. Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis. J Cardiovasc Surg2008;49:213–33
29.
AbelaR, LiamisA, PrionidisI, Reverse foam sclerotherapy of the great saphenous vein with sapheno-femoral ligation compared to standard and invagination stripping: a prospective clinical series. Eur J Vasc Endovasc Surg2008;36:485–90
30.
BountouroglouDG, AzzamM, KakkosSK, Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial. Eur J Vasc Endovasc Surg2006;31:93–100
31.
BelcaroG, CesaroneMR, Di RenzoA, Foam-sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial). Angiology2003;54:307–15
32.
Gonzalez-ZehR, ArmisenR, BarahonaS. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results. J Vasc Surg2008;48:940–6
33.
TheivacumarNS, DellagrammaticasD, MavorAI, GoughMJ. Endovenous laser ablation: does standard above-knee great saphenous vein ablation provide optimum results in patients with both above- and below-knee reflux? A randomized controlled trial. J Vasc Surg2008;48:173–8
34.
GilletJL, GuedesJM, GuexJJ, Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology2009;24:86
35.
JiaX, MowattG, BurrJM, Systematic review of foam sclerotherapy for varicose veins. Br J Surg2007;94:925–36
36.
MyersKA, JolleyD. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg2008;36:602–5
37.
GilletJL, GuedesJM, GuexJJ, Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology2009;24:86
CeulenRP, SommerA, VernooyK. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med2008;358:1525–6
40.
RushJE, WrightDD. More on microembolism and foam sclerotherapy. N Engl J Med2008;359:656
41.
GibsonKD, RegonJD, ShortellC, Proprietory polidocanal endovenous microfoam bubble embolization does not cause cerebral injury. Phlebology2009;24:85
42.
NeuhardtD, MorrisonN, RogersC, Salles-CunhaS. Emboli detection in the middle cerebral artery concurrent with treatment of lower extremity superficial venous insufficiency with foam sclerotherapy. Phlebology2009;24:88
43.
HillD, HamiltonR, FungT. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein. J Vasc Surg2008;48:934–9
44.
YamakiT, NozakiM, SakuraiH, TakeuchiM, SoejimaK, KonoT. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg2009;37:343–8
45.
MorrisonN, NeuhardtDL, RogersCR, Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg2008;47:830–6
46.
MorrisonN, NeuhardtD, RogersC, Studies on foam migration. Phlebology2009;24:88
